Evidence map›Paper›PMID 39512551›Full record

ArticleInternational journal of critical illness and injury science

Assessment of quality of life in follow-up patients with COVID-19 pneumonia: A prospective, observational study from a tertiary care center.

Tatikonda Chandra Mouli, Rupali Patnaik, Samir Samal, Shakti Bedanta Mishra

Abstract read
In one paragraph

Article in International journal of critical illness and injury science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tatikonda Chandra MouliDepartment of Critical Care Medicine, Yasoda Hospital, Secunderabad, Telangana, India.
Rupali PatnaikDepartment of Critical Care Medicine, IMS and SUM Hospital, SOA Deemed to be University, Bhubaneswar, Odisha, India.
Samir SamalDepartment of Critical Care Medicine, IMS and SUM Hospital, SOA Deemed to be University, Bhubaneswar, Odisha, India.
Shakti Bedanta MishraDepartment of Critical Care Medicine, IMS and SUM Hospital, SOA Deemed to be University, Bhubaneswar, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study intended to assess the quality of life (QOL) with telephonic interview using the Short Form 12 (SF-12) Scale in follow-up patients admitted to the intensive care unit (ICU) with COVID-19 pneumonia. Methods: This prospective, noninterventional follow-up study was conducted at a tertiary care center. COVID-19 pneumonia patients discharged from ICU were recruited for telephonic interviews. Interviews were performed using SF-12 Scale to assess QOL 6 months after discharge. The SF-12 survey measures general health status in eight domains. A radar chart was used for the interpretation of health component scores. Results: One hundred and fifty patients could complete the telephonic interview. The first-stage depression risk was 50%, which was 30% more than general position incidence (20%). As compared to the general population, physical component summary (PCS-12) was 60% below and mental component summary (MCS-12) was 67% below the general norm. Role emotional was the most affected followed by role physical. Conclusions: QOL in follow-up ICU patients with COVID-19 pneumonia was worse in terms of physical and mental scores. By employing a comprehensive, longitudinal assessment of QOL in follow-up patients, using validated SF-12 Scale, this study captures a multifaceted view of their health status postrecovery.

Indexed as

COVID-19critical carequality of life

Identifiers

PMID39512551
PMCPMC11540191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.